SOLLINI, Martina
 Distribuzione geografica
Continente #
NA - Nord America 1.908
EU - Europa 652
AS - Asia 503
AF - Africa 63
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 3.144
Nazione #
US - Stati Uniti d'America 1.885
CN - Cina 248
SG - Singapore 174
FI - Finlandia 172
IE - Irlanda 131
IT - Italia 85
DE - Germania 75
NG - Nigeria 63
SE - Svezia 55
IN - India 45
GB - Regno Unito 30
NL - Olanda 28
FR - Francia 25
CA - Canada 22
BE - Belgio 13
RU - Federazione Russa 13
IR - Iran 10
EU - Europa 8
AR - Argentina 7
AT - Austria 7
TR - Turchia 7
ES - Italia 5
HK - Hong Kong 5
TW - Taiwan 4
CH - Svizzera 3
IL - Israele 3
JP - Giappone 3
HR - Croazia 2
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UA - Ucraina 1
Totale 3.144
Città #
Chandler 280
Wilmington 224
Shanghai 203
Helsinki 172
Ashburn 157
San Mateo 147
Dublin 131
Singapore 123
Boardman 121
New York 96
Ann Arbor 91
Benin City 63
Lawrence 60
Princeton 60
Leawood 41
Pune 41
Amsterdam 28
Fairfield 26
Paris 25
Seattle 24
London 23
Toronto 22
Woodbridge 22
Monmouth Junction 21
Milan 20
Los Angeles 18
Santa Clara 14
Brussels 13
Redwood City 13
Florence 11
Norwalk 9
Beijing 8
Moscow 8
Kocaeli 7
Phoenix 7
Zhengzhou 7
Des Moines 6
Redmond 6
Falkenstein 5
Hangzhou 5
Munro 5
San Diego 5
Vienna 5
Andover 4
Munich 4
Chengdu 3
Jacksonville 3
Mestre 3
Osimo 3
Pozzuoli 3
Abbiategrasso 2
Ardabil 2
Avigliano 2
Bari 2
Canegrate 2
Chongqing 2
Ferrara 2
Hull 2
Issiglio 2
Kaohsiung City 2
Kwun Hang 2
Manchester 2
Naples 2
Norfolk 2
Nuremberg 2
Trento 2
Turin 2
Zagreb 2
Augusta 1
Bangkok 1
Baoding 1
Belgrade 1
Bologna 1
Bradford 1
Bratislava 1
Buffalo 1
Changchun 1
Clifton 1
Cologno Monzese 1
Dhaka 1
Edison 1
Esslingen am Neckar 1
Genoa 1
Keflavik 1
Leninsk-kuznetskiy 1
Ljubljana 1
Meieki 1
Newark 1
Novokuznetsk 1
Parabita 1
Pullach im Isartal 1
Pécs 1
Saint Paul 1
Salzburg 1
San Francisco 1
Seoul 1
Shenzhen 1
Shijiazhuang 1
St Petersburg 1
Sydney 1
Totale 2.464
Nome #
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 77
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 72
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 68
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 66
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 59
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 59
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 58
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 56
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 56
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 55
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 54
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 52
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 52
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 51
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 49
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 48
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 48
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 48
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 47
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 47
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 46
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 46
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 45
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 44
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 43
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 42
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 42
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 40
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 39
Cardiac molecular pathways influenced by doxorubicin treatment in mice 39
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 38
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 38
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 37
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 35
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 35
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 35
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. 34
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 34
The "3M" Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary 34
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 33
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 33
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 32
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 31
Total glycolytic volume and biological markers in mesothelioma patients 30
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 27
PET/CT radiomics in breast cancer: Mind the step 27
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 27
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 26
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 25
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 25
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 25
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 25
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 25
Radiomics of Liver Metastases: A Systematic Review 24
PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors 23
Methodological framework for radiomics applications in Hodgkin’s lymphoma 23
The use of 18F-FDG-PET/CT in the diagnostic workup of CIED infections: another perspective 22
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 22
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 22
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 22
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 22
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 21
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 21
18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study 21
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 19
Alternative Nuclear Imaging Tools for Infection Imaging 19
PET/MRI in Infection and Inflammation 19
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 19
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 18
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results 18
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 18
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 18
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 17
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 17
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 16
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 16
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 16
[18F]FDG-PET/CT texture analysis in thyroid incidentaloma: preliminary results 15
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis 15
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 15
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 15
Detection of Device Infection Using Nuclear Cardiology Imaging 15
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 14
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 14
(18)F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer 14
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 14
Comprehensive meta-analysis on [18F] FDG PET/CT and radiolabelled leukocyte SPECT–SPECT/CT imaging in infectious endocarditis and cardiovascular implantable electronic device infections 13
Combined imaging approach to diagnose a meningioma in a patient with prostate and lung cancers 12
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach 12
Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections 12
Current Status of Molecular Imaging in Infections 11
The Role of Nuclear Cardiac Imaging in Infective Endocarditis 11
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 11
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 11
Diagnostic performances of [18f]fluorocholine positron emission tomography in brain tumors 11
Image acquisition and interpretation criteria for 99mTc-HMPAO-labelled white blood cell scintigraphy: results of a multicentre study 11
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 11
New approaches for imaging and therapy of solid cancer 11
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 11
On the Automation of Radiomics-based Identification and Characterization of NSCLC 10
Totale 3.021
Categoria #
all - tutte 31.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 0 3
2020/2021503 3 3 1 2 4 167 57 49 93 56 9 59
2021/2022426 55 5 25 85 16 7 8 45 35 23 101 21
2022/20231.030 136 54 79 71 84 45 10 108 186 107 127 23
2023/20241.076 71 109 211 81 38 169 80 44 29 19 94 131
2024/2025235 37 7 12 16 16 147 0 0 0 0 0 0
Totale 3.273